Elicio Therapeutics Inc. (ELTX)
Healthcare
Biotechnology
2.90 $
+2.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Elicio Therapeutics Inc. (ELTX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -37 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2012 | 2013 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1.1 | 1.9 | -8.0 | -25 | -23 | -24 | -22 | -33 | -37 | -37 | |
| 0.5 | 0.5 | 0.0 | 0.5 | 0.6 | 0.3 | 1.1 | 1.2 | 1.2 | 1.1 | |
| – | – | – | 0.1 | 0.3 | 0.6 | 0.6 | 1.2 | 1.5 | 2.7 | |
| – | – | – | 0.2 | 0.4 | 1.3 | 5.1 | – | – | – | |
| -0.1 | 0.3 | 3.1 | 9.8 | 26 | 0.9 | -0.2 | -0.1 | 4.0 | -3.4 | |
| 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.5 | 0.7 | 0.1 | 0.1 | 0.0 | |
| 0.0 | -0.1 | – | -0.2 | 0.0 | -0.5 | -0.7 | 0.0 | -0.1 | 0.0 | |
| – | – | – | -0.4 | 0.0 | – | 0.0 | -0.2 | -0.5 | – | |
| – | – | – | 15 | 15 | 15 | 0.0 | 10 | 20 | 0.0 | |
| -0.4 | -1.2 | 32 | 4.9 | 52 | 19 | 21 | 39 | 42 | 37 | |
| 0.6 | 0.7 | 23 | -20 | 29 | -5.1 | -81 | 5.9 | 5.2 | -0.2 | |
| 1.0 | 1.9 | -8.0 | -25 | -23 | -24 | -23 | -33 | -37 | -37 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.